Public Reporting


ACO Name and Location

MD Valuecare, LLC
8001 Franklin Farms Drive, Suite 130
Richmond, VA 23229

ACO Primary Contact

Shannon Lodge, ACO Administrator
8001 Franklin Farms Drive, Suite 130
Richmond VA 23229

Organizational Information

ACO Participants

“(ACO participants are not in a joint venture)”
Chickahominy Family Practice

Commonwealth Primary Care

Dominion Medical Associates

Virginia Diabetes and Endocrinology

ACO Participants in Joint Ventures Between ACO Professionals and Hospitals


ACO Governing Body

Dr. John Kowalski

Dr. Damian Covington

Dr. Paul McTamaney

Voting Member (11.11%), Medicare Beneficiary Representative

Dr. Dave Taminger

Dr. Steve Young

Dr. Ken Zelenak

Dr. Shea Puttkammer

Voting Member (11.11%), ACO Participant Representative, Virginia Diabetes and Endocrinology

Key Clinical and Administrative Leadership

ACO Executive

Dr. Ken Zelenak

Medical Director

Shannon Lodge

Compliance Official

Dr. Ken Zelenak

Quality Assurance / Improvement Officer

ACO Committees and Committee Leadership

Quality Committee: Dr. Ken Zelenak, Chair

Managing Committee: Katie Nunn, Chair

Specialist Mobilization Committee: Dr. Mark Monahan, Co-Chair and Dr. Johnny Wong, Co-Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

Network of individual practices of ACO professionals.

Shared Savings and Losses

Amount of Shared Savings and Losses

Second Agreement Period

  • Performance Year 2017, $3,701,488

First Agreement Period

  • Performance Year 2016, $1,809,663
  • Performance Year 2015, $0
  • Performance Year 2014, $0

How Shared Savings Are Distributed

Second Agreement Period
Performance Year 2017

  • Proportion invested in infrastructure: 41%
  • Proportion invested in redesigned care processes/resources: 10% percent or dollar amount
  • Proportion of distribution to ACO participants: 49%

First Agreement Period
Performance Year 2016

  • Proportion invested in infrastructure: 100%
  • Invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 0%

Performance Year 2015 – N/A
Performance Year 2014 – N/A

Payment Rule Waivers:
Our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

2017 Reporting Period
ACO#Measure NameACO Performance Rate (%)Mean Performance Rate (SSP ACOs) (%)
ACO-1CAHPS: Getting Timely Care, Appointments, and Information 75.8080.60
ACO-2CAHPS: How Well Your Providers Communicate 92.8193.13
ACO-3CAHPS: Patients’ Rating of Provider 92.2092.31
ACO-4CAHPS: Access to Specialists 79.9783.32
ACO-5CAHPS: Health Promotion and Education63.9360.30
ACO-6CAHPS: Shared Decision Making 74.5675.85
ACO-7CAHPS: Health Status/Functional Status 74.2473.05
ACO-34CAHPS: Stewardship of Patient Resources*26.7325.68
ACO-8Risk Standardized, All Condition Readmission14.7015.01
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)* Readmission17.7618.46
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes*44.4653.95
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure*70.3879.16
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions53.1961.74
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))1.171.93
ACO-11Percent of PCPs who Successfully Meet Meaningful Use Requirements100.0098.48
ACO-12Medication Reconciliation48.3175.32
ACO-13Falls: Screening for Future Fall Risk 94.1474.38
ACO-44Imaging Studies for Low Back Pain64.5267.32
ACO-14Preventive Care and Screening: Influenza Immunization85.1672.52
ACO-15Pneumonia Vaccination Status for Older Adults87.1372.92
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up65.5770.69
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention96.9190.48
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan87.5461.98
ACO-19Colorectal Cancer Screening76.1164.58
ACO-20Breast Cancer Screening76.9470.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control 7.5716.74
ACO-41Diabetes: Eye Exam*75.4150.37
ACO-28Hypertension: Controlling High Blood Pressure 76.2771.47
ACO-30Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic92.8286.86
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “MD Valuecare, LLC” or “MD Value Care” to view the quality performance results. This ACO can also be found by using the ACO ID A39151 in the public use files on